Amylyx Pharmaceuticals (AMLX) Asset Utilization Ratio (2023 - 2024)
Historic Asset Utilization Ratio for Amylyx Pharmaceuticals (AMLX) over the last 4 years, with Q3 2025 value amounting to 0.09.
- Amylyx Pharmaceuticals' Asset Utilization Ratio fell 8734.12% to 0.09 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.09, marking a year-over-year decrease of 8734.12%. This contributed to the annual value of 0.32 for FY2024, which is 6614.71% down from last year.
- Latest data reveals that Amylyx Pharmaceuticals reported Asset Utilization Ratio of 0.09 as of Q3 2025, which was down 8734.12% from 0.13 recorded in Q2 2025.
- Over the past 5 years, Amylyx Pharmaceuticals' Asset Utilization Ratio peaked at 0.93 during Q1 2024, and registered a low of 0.0 during Q2 2022.
- For the 4-year period, Amylyx Pharmaceuticals' Asset Utilization Ratio averaged around 0.39, with its median value being 0.28 (2023).
- In the last 5 years, Amylyx Pharmaceuticals' Asset Utilization Ratio skyrocketed by 4468287.32% in 2023 and then crashed by 8734.12% in 2025.
- Amylyx Pharmaceuticals' Asset Utilization Ratio (Quarter) stood at 0.09 in 2022, then skyrocketed by 826.71% to 0.88 in 2023, then tumbled by 40.3% to 0.52 in 2024, then tumbled by 82.02% to 0.09 in 2025.
- Its Asset Utilization Ratio stands at 0.09 for Q3 2025, versus 0.13 for Q2 2025 and 0.13 for Q1 2025.